Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on December 2025 ACIP Meeting
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…
Learn more
BIO Statement on the Retirement of Richard Pazdur…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA.“Dr. Pazdur has dedicated decades of his career…
Learn more
BIO Statement on House Passage of Mikaela Naylon…
WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Supports State and Congressional Efforts to Reject Gratuitous Requests From Oil Industry
May 8, 2020
Washington, D.C. (May 8, 2020) – The Biotechnology Innovation Organization (BIO) today released the following statement in support of the Governors' Biofuels Coalition letter urging EPA to reject unjustifiable Renewable Fuel Standard (RFS)…
Administration’s Benefit Rule Threatens Access and Affordability of Prescription Medicines
May 7, 2020
BIO’s Tom DiLenge, President of Advocacy, Law & Public Policy Division issued the following statement today after the Trump administration adopted a “Notice of Benefit and Payment Parameters for 2021” that allows health plans to block drug…
New Online IP Marketplace Will Foster Collaboration in Race to Eradicate COVID-19
May 4, 2020
To help in the response to the coronavirus pandemic, the U.S. Patent and Trademark Office today launched a new online platform, called “Patents 4 Partnerships,” to share patent information for various technologies to facilitate greater collaboration…
BIO Helps Capital Area Food Bank Meet Demand for Food in Wake of COVID-19 Outbreak
April 15, 2020
The Biotechnology Innovation Organization (BIO) is donating $10,000 to the Capital Area Food Bank to help the organization meet the increased demand for healthy and fresh food in the Washington, D.C. community due to the coronavirus outbreak. “As…
2020 BIO International Convention Now Fully Digital
April 3, 2020
The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO International Convention scheduled for June 8-11 in San Diego to an online platform, in lieu of an in-person event for this year. The decision was based…
BIO Summit Accelerates Collaboration Between Government & Industry Leaders in Fight Against Covid-19
March 25, 2020
The Biotechnology Innovation Organization (BIO) this week hosted a productive virtual summit intended to foster collaboration among key government agencies and biopharmaceutical innovators with one goal: eradicating Covid-19. The two-day virtual…
America’s Biopharmaceutical Companies Working Around the Clock to Beat Coronavirus
March 20, 2020
Companies are Coming Together to Achieve Shared Goal of Eradicating the Virus  Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) underscored the industry’s commitment…
Maine Takes Significant Step in Addressing Climate Challenge Through Renewable Chemicals Tax Credit
March 19, 2020
Maine is speeding up its transformation to a 21st-century, biobased economy with the passing of the Renewable Chemicals Tax Credit, which will foster the production of environmentally friendly innovations—like renewable chemicals and biobased…
Media Advisory: World’s Largest Biopharmaceutical Organization to Host Two-Day Virtual Summit on Coronavirus
March 18, 2020
BIO-Led Summit to Build Collaboration Between Biopharma Industry, Government Leaders & Scientific Experts  Responding to the rapidly evolving COVID-19 public health crisis, the Biotechnology Innovation Organization (BIO) is taking the…
SEC Regulatory Changes Provide Small Biotech Companies Relief from Burdensome Requirements
March 12, 2020
The Securities and Exchange Commission (SEC) has adopted regulatory changes to provide small public companies with a temporary exemption from Sarbanes-Oxley 404(b) compliance. 404(b) requires public companies to report on the internal controls they…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today